ATE40854T1 - Therapeutische zusammensetzungen mit antiviraler wirksamkeit. - Google Patents
Therapeutische zusammensetzungen mit antiviraler wirksamkeit.Info
- Publication number
- ATE40854T1 ATE40854T1 AT84113011T AT84113011T ATE40854T1 AT E40854 T1 ATE40854 T1 AT E40854T1 AT 84113011 T AT84113011 T AT 84113011T AT 84113011 T AT84113011 T AT 84113011T AT E40854 T1 ATE40854 T1 AT E40854T1
- Authority
- AT
- Austria
- Prior art keywords
- bvdu
- acyclovir
- compositions
- antiviral activity
- therapeutic compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- ODZBBRURCPAEIQ-DJLDLDEBSA-N Brivudine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C=CBr)=C1 ODZBBRURCPAEIQ-DJLDLDEBSA-N 0.000 abstract 3
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 3
- 229960004150 aciclovir Drugs 0.000 abstract 3
- 239000007858 starting material Substances 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23545/83A IT1170232B (it) | 1983-10-31 | 1983-10-31 | Composizioni terapeutiche ad attivita' antivirale |
| EP84113011A EP0143987B1 (de) | 1983-10-31 | 1984-10-29 | Therapeutische Zusammensetzungen mit antiviraler Wirksamkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE40854T1 true ATE40854T1 (de) | 1989-03-15 |
Family
ID=11208018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84113011T ATE40854T1 (de) | 1983-10-31 | 1984-10-29 | Therapeutische zusammensetzungen mit antiviraler wirksamkeit. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0143987B1 (de) |
| JP (1) | JPS60120814A (de) |
| AT (1) | ATE40854T1 (de) |
| DE (1) | DE3476784D1 (de) |
| IT (1) | IT1170232B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8700366A (nl) * | 1987-02-13 | 1988-09-01 | Stichting Rega V Z W | Combinatie van fu met bvdu als middel tegen adenocarcinoom. |
| GB8829571D0 (en) * | 1988-12-19 | 1989-02-08 | Wellcome Found | Antiviral compounds |
| HUT72604A (en) * | 1992-12-03 | 1996-05-28 | Merrell Dow Pharma | Compositions containing acyclovir-like compounds and 2`-vinyl substituted nucleoside analogs for the treatment of viral infections |
| WO1996001638A1 (en) * | 1994-07-11 | 1996-01-25 | Hoechst Marion Roussel, Inc. | Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy |
| US5789589A (en) * | 1996-04-22 | 1998-08-04 | Drug Innovation & Design, Inc. | Guanine analog phosphates |
| US6180790B1 (en) | 1997-05-15 | 2001-01-30 | Drug Innovation And Design, Inc. | Methods of preparing acyclovir prodrugs |
| CA2289969A1 (en) * | 1997-05-15 | 1998-11-19 | Drug Innovation & Design, Inc. | Acyclovir diester derivatives |
| ITMI20010009A1 (it) * | 2001-01-03 | 2002-07-03 | Menarini Ricerche Spa | Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera |
| DE10108851A1 (de) | 2001-02-23 | 2002-09-12 | Resprotect Gmbh | Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
| ATE24836T1 (de) * | 1982-02-12 | 1987-01-15 | Ens Bio Logicals Inc | Antivirale zusammensetzungen. |
-
1983
- 1983-10-31 IT IT23545/83A patent/IT1170232B/it active
-
1984
- 1984-10-29 DE DE8484113011T patent/DE3476784D1/de not_active Expired
- 1984-10-29 AT AT84113011T patent/ATE40854T1/de not_active IP Right Cessation
- 1984-10-29 EP EP84113011A patent/EP0143987B1/de not_active Expired
- 1984-10-31 JP JP59230031A patent/JPS60120814A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0143987A1 (de) | 1985-06-12 |
| JPS60120814A (ja) | 1985-06-28 |
| EP0143987B1 (de) | 1989-02-22 |
| DE3476784D1 (en) | 1989-03-30 |
| IT1170232B (it) | 1987-06-03 |
| IT8323545A0 (it) | 1983-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ228645A (en) | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections | |
| IL100040A0 (en) | Nucleic acid amplification by two-enzyme,self-sustained sequence replication | |
| MX164509B (es) | Tiazoles substituidos y su uso como fungicidas | |
| WO1993017651A3 (de) | Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung | |
| ATE103468T1 (de) | Herbizides wirkstoffkonzentrat. | |
| ATE40854T1 (de) | Therapeutische zusammensetzungen mit antiviraler wirksamkeit. | |
| DE68921080D1 (de) | Synergistische, oberflächenaktive Zusammensetzungen. | |
| BR9105902A (pt) | Novo polipeptídeo | |
| DE3861251D1 (de) | Negative resistzusammensetzungen. | |
| ATE36331T1 (de) | Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung. | |
| ES2102772T3 (es) | Compuesto citotoxico y antiviral. | |
| ZA782781B (en) | Pharmacologically active substituted 1,2,4-triazines | |
| AU570552B2 (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
| NZ219313A (en) | Htlv-iii (hiv) virus with modifications to the tat gene | |
| DK610287A (da) | Peptider, deres fremstilling og anvendelse | |
| ZA896230B (en) | Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodefeciency syndrome | |
| SU717773A1 (ru) | Микропрограммный процессор | |
| SU660914A1 (ru) | Вакуумный захват | |
| Clair-Tisdall | The Sources of Islam | |
| IT8921095A0 (it) | Composizione per l'aumento del guadagno di peso. | |
| Baxter | Atlas | |
| Smith | Anti-viral compositions. | |
| JPS6471815A (en) | Antiviral composition containing 5-amino-2- (4-methylpiperidine-1-yl)phenyl-4- chlorophenylmethanone | |
| DK166388A (da) | 3,4,6-trisubstituerede 1,2,4-triazin-5(4h)-oner, deres fremstilling og anvendelse som herbicider | |
| SU1538491A1 (ru) | Сетчатый сополимер винилбензиламин-n-метиленфосфоновой кислоты в качестве сорбента индия из концентрированных сернокислых растворов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |